Ron Schey is a Gastroenterology physician affiliated with Temple University. OpenAlex indexes 172 publications with 2,698 citations (h-index 26); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
743 Jefferson Ave
Scranton, PA 185101635
Telephone
570-344-9457Provider last certified this registry record 31 Jul 2024.
Clinical trials
- Movantik for Opioid-Related Esophageal Disorders
Sponsor: Temple University
- Investigation of Cannabinoid Receptor Agonist Dronabinol in Patients With Functional Chest Pain
Sponsor: Temple University
- Dexilant Treatment in Gastrointestinal Reflux Disease (GERD Related Non Cardiac Chest Pain
Sponsor: University of Iowa
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novo Nordisk IncProgram year20251 payment
- Regeneron Healthcare Solutions, Inc.Program year20251 payment
- Medtronic, Inc.Program year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
93.4%Proton pump inhibitor31%Pantoprazole Sodium83%Omeprazole17%Part D<11 patientsH2 blocker23.9%Famotidine100%Part D≥15 patients+ 3 more classes in this area
Cancer & immunology
6.6%TNF inhibitor6.6%Humira Pen100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Factors that contribute to the impairment of quality of life in gastroparesis
Neurogastroenterology & Motility
2021 - Constipation in Patients With Symptoms of Gastroparesis: Analysis of Symptoms and Gastrointestinal Transit
Clinical Gastroenterology and Hepatology
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Gerard Criner, MD
Temple University
Yoshiya Toyoda, MD, PhD
Temple University
Lyle Ostrow, MD, PhD
Temple University
Michel Pontari, MD
Temple University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”